Sort by
Refine Your Search
-
Employer
-
Field
-
French National Institute for Health Research (INSERM) | Lille, Nord Pas de Calais | France | 2 months ago
therapeutics for Alzheimer’s disease by integrating biostatistics, bioinformatics, and Big Data analytics. Key Responsibilities Perform statistical analyses using the R programming language. Develop and apply
-
at a university or higher education institution, and the internship must be a mandatory component of their program of study; The compensation for this internship is 832€/month + lunch vouchers
-
Agreement and other legal documents) and prepare updates when necessary to ensure compliance with the rules and procedures; Assist partners on the administrative aspects of the project; Develop and implement
-
) involving the recruitment, instruction, motion capture and movement analysis of patients and healthy control subjects. Contribute to research activities in particular related to adopting AI-based methods
-
readiness. The successful candidate is expected to develop a program that bridges basic discovery and translational application, with the potential to advance precision ophthalmology for rare genetic diseases
-
vision frameworks, applied machine learning techniques, and medical imaging standards Develop user-friendly front-end interfaces, web dashboards, or software demonstrators to make biomedical image analysis
-
Cardioembolic Stroke Risk Stratification using AI Accelerated Patient-Specific Blood Flow Simulation
, but current strategies to identify patients in whom it will be beneficial lack efficiency. Aim The main goal of this project is to develop innovative point of care tools for the prediction and
-
to mid-career level) to develop creative research to alleviate and cure deafness through innovative approaches. Experts in inner ear therapy including pharmacological treatment, gene/epigenetic therapy and
-
collaborative, with the goal of using imaging to understand the fundamentals of cellular/tissue biology and their subversion by pathological and infectious processes. Our R&D is based on the need to develop